Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Prostate Cancer Equipment Supplied In Europe
39 equipment items found
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
FIRMAGON® (degarelix) is a treatment for men with advanced hormone-dependent prostate cancer. It has a novel mechanism of action that is different from traditional LHRH agonist therapy commonly used. Decreasing testosterone levels can cause the cancer cells to die, thus reducing the size of the tumour and delaying its growth. ...
Manufactured by:EDAP TMS based inVaulx-en-Velin, FRANCE
Focal treatment strategy for Prostate Cancer (PCa) is playing a growing role in today's surgical practice. By combining the latest imaging and treatment technologies, Focal One® brings the answer to current requirements for ideal focal therapy: accurate and MR-fused imaging, non-invasive approach, precise and efficient therapeutic HIFU energy and treatment ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the ...
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate tissue-based test to predict non-evolutive localized prostate cancer (LPCa). ...
Manufactured by:EDAP TMS based inVaulx-en-Velin, FRANCE
The ExactVu™ micro-ultrasound platform provides the most practical solution as a new tool for urologists or radiologists to perform targeted biopsies within a standard urological workflow. The unique 29MHz frequency allows to visualize details unseen before in any prostate ultrasound image, detect suspicious areas in real-time and take a biopsy sample as representative of ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LOCAMETZ, after radiolabeling with gallium-68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy, with suspected recurrence based on elevated serum ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
Manufactured by:LAVA Therapeutics N.V. based inUtrecht, NETHERLANDS
LAVA-1207, a gamma-delta bsTCE targeting the prostate specific membrane antigen (PSMA), has also demonstrated preclinical proof-of-concept. We expect to initiate a Phase I/IIa trial in metastatic castration-resistant prostate cancer in the second half of ...
Manufactured by:Vivesto AB based inSolna, SWEDEN
Docetaxel micellar is a product candidate in early clinical development and is a novel formulation that combines XR-17 with docetaxel - a well-established cytotoxin, currently administered intravenously and containing ethanol. In June 2020, Vivesto partnered with the Swiss Group for Clinical Cancer Research (SAKK) with the aim of conducting the first clinical study on the ...
Manufactured by:Exact Imaging based inMarkham, ONTARIO (CANADA)
ExactVu micro-ultrasound system for targeted biopsies for prostate cancer. ...
by:Debiopharm based inLausanne, SWITZERLAND
Triptorelin decreases the serum testosterone to castrate levels (estradiol in females). Androgen deprivation stops the growth of the androgen dependent prostate cancer, alleviating pain and improving thus the quality of life of patients. GnRH agonist treatment achieves similar overall survival rates in advanced prostate cancer as ...
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
The ExoDx Prostate is a simple, non-invasive urine test that can discriminate the risk of aggressive prostate cancer (defined as Gleason Score ≥7). This test is now available as an At-Home Collection Kit that can be initiated by an electronic order signed by the physician and sent directly to the patient’s home for ...
Manufactured by:InnoMedicus based inCham, SWITZERLAND
Earlier, precise diagnostic of prostate cancer demands a paradigm change respectively a new treatment pathway. SONABLATE HIFU is the image-guided, non-invasive surgical ablation system that delivers precise, focused and controlled ablative energy and allows to create a customized treatment for each patient’s individual prostate ...
Manufactured by:Ardigen based inKraków, POLAND
This process can be applied to various scoring systems, such as the Nancy and Geboes Histological score (for inflammatory bowel disease data) or the Gleason score (for prostate cancer ...
Manufactured by:INTERmedic Arfran based inBarcelona, SPAIN
INTERmedic, worldwide leader in photodynamic therapy for pulmonology (lung cancer), gastroenterology (Barrett’s esophagus, esophageal cancer), urology (prostate cancer) among others, presents Multidiode™ PDT, an innovative technology to treat dermatological pathologies such as basal cell carcinoma, cholangiocarcinoma ...
Manufactured by:ABX Advanced Biochemical Compounds GmbH based inRadeberg, GERMANY
Radelumin is an advanced radiopharmaceutical product designed for diagnostic imaging, particularly in the detection of prostate-specific membrane antigen (PSMA) in patients. The injectable solutions of Radelumin are available in concentrations of 1300 MBq/ml and 2000 MBq/ml, using [18F]PSMA-1007 as the active compound. It plays a critical role in enhancing the precision of PET ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Under the guidance of Academician Sun Yinghao, RALRP was provided to a 65 year old local patient, who was admitted to the hospital for early prostate cancer, the whole surgery lasted 1.5 hours. Post-surgery, the patient recovered with good ...
Manufactured by:Soteria Medical BV based inArnhem, NETHERLANDS
Soteria Medical BV’s goal is to improve MR-guided biopsies (MRgBx) of the prostate. Soteria has developed a robot for MR-guided interventions - based on a novel, patented motor principle. The main objectives are to improve accuracy, duration, cost and reliability of existing procedures. We are enabling the Physician to perform a targeted prostate biopsy ...
Manufactured by:Blue Earth Diagnostics based inOxford, UNITED KINGDOM
The targeting molecule delivers a therapeutic dose of radiation to kill tumour cells. Blue Earth Diagnostics acquired exclusive, worldwide rights to radiohybrid Prostate Specific Membrane Antigen (rhPSMA) targeted technology in order to expand its oncology imaging and theranostics portfolio. The Company is investigating the use of rhPSMA (18F) as a diagnostic imaging agent for ...